In hepatoblastoma (HB), SLC7A1, acting as a substrate of the tumor suppressor gene SPOP, modulates the progression of HB through the regulation of arginine metabolism, thereby offering a novel therapeutic target for HB (He et al., 2020). This evidence concerns the gene SLC7A1 and hemoglobin measurement.